Immunotherapy improves survival in people with advanced Hodgkin lymphoma, study shows - CNN
- Immunotherapy improves survival in people with advanced Hodgkin lymphoma, study shows CNN
- New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma U.S. News & World Report
- Wilmot Cancer Institute trial shows a new Hodgkin treatment has promise WXXI News
- Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma Medpage Today
- Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma Roswell Park Comprehensive Cancer Center